AtaiBeckley (ATAI) Change in Accured Expenses (2020 - 2026)

AtaiBeckley's (ATAI) quarterly Change in Accured Expenses came in at -$4.1 million in Q1 2026, down 194.27% year-on-year from $4.4 million in Q1 2025, and down 194.27% quarter-over-quarter from -$1.4 million in Q1 2025.

AtaiBeckley (ATAI) Change in Accured Expenses (2020 - 2026) Analysis & Trends

AtaiBeckley (ATAI) has 6 years of Change in Accured Expenses data on file, last reported at -$3.6 million in Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses fell 167.62% year-over-year to -$3.6 million; the trailing twelve-month figure through Sep 2025 stood at -$2.1 million (up 4.54% YoY), and the FY2024 full-year result was -$6.2 million, down 87.18% from the prior year.
  • Change in Accured Expenses slipped to -$4.1 million in Q1 2026 per ATAI's latest filing, from -$1.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at -$1.4 million in Q1 2025 and bottomed at -$4.1 million in Q1 2026.
  • A 5-year average of -$119052.6 and a median of -$270000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses soared 6546.73% in 2021 and plunged 404.44% in 2024, its largest moves.
  • Tracing ATAI's Change in Accured Expenses over 5 years: stood at $2.5 million in 2021, then tumbled by 248.71% to -$3.7 million in 2022, then soared by 144.5% to $1.6 million in 2023, then tumbled by 246.24% to -$2.4 million in 2024, then plunged by 51.24% to -$3.6 million in 2025.
  • Business Quant data shows ATAI's Change in Accured Expenses at -$3.6 million in Q3 2025, $5.7 million in Q2 2025, and -$1.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - 1.13 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 931,000.00
4 BeOne Medicines 472.40 Bn 467.61 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.23 Bn 114.98 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.46 Bn 62.46 Bn - -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn -176.03 Mn
10 AtaiBeckley 1.56 Bn 1.56 Bn - -3.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.11 Mn
Mar 31, 2026 -4.11 Mn
Sep 30, 2025 -3.65 Mn
Sep 30, 2025 -3.65 Mn
Jun 30, 2025 5.68 Mn
Jun 30, 2025 5.68 Mn
Mar 31, 2025 -1.40 Mn
Mar 31, 2025 -1.40 Mn
Mar 31, 2025 -1.71 Mn
Mar 31, 2025 -1.71 Mn
Dec 31, 2024 -2.41 Mn
Dec 31, 2024 -2.41 Mn
Sep 30, 2024 -1.36 Mn
Sep 30, 2024 -1.36 Mn
Jun 30, 2024 1.82 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 -4.29 Mn
Mar 31, 2024 -4.29 Mn
Dec 31, 2023 1.65 Mn
Dec 31, 2023 1.65 Mn